Citation Impact
Citing Papers
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
2008 StandoutScience
Benchmarking the stability of human detergent-solubilised voltage-gated sodium channels for structural studies using eel as a reference
2015 StandoutNobel
Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance
2014 Standout
Diffusion tensor imaging: Concepts and applications
2001 Standout
Restless Legs Syndrome
2008
Randomized trials of dopamine agonists in restless legs syndrome: A systematic review, quality assessment, and meta-analysis
2010
Sodium channelopathies of skeletal muscle result from gain or loss of function
2010
Updating P300: An integrative theory of P3a and P3b
2007 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: Association with ferritin levels
2009
Linkage of Familial Amyotrophic Lateral Sclerosis With Frontotemporal Dementia to Chromosome 9q21-q22
2000
Rapidly progressive aphasic dementia and motor neuron disease
1993
Physical Trauma and Family History of Neurodegenerative Diseases in Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
1999
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses
2012
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
2006 Standout
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
2000 Standout
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
1997 StandoutNobel
Amyotrophic Lateral Sclerosis
2001 Standout
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
2003 Standout
Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis
1996 StandoutNobel
Circadian rhythms in the eye: The physiological significance of melatonin receptors in ocular tissues
2007
Le potentiel évoqué cognitif P300 (II) : variabilité interindividuelle et application clinique en psychopathologie
2000
Intrinsic disorder in proteins associated with neurodegenerative diseases
2009
Posterior leukoencephalopathy without severe hypertension
1998
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Frontotemporal lobar degeneration
1998 Standout
Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles.
1995
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.
1994
Etiology and pathogenesis of prion diseases.
1995 StandoutNobel
Works of W. Emser being referenced
Melatonin decreases the amplitude of the b-wave of the human electroretinogram
1993
The P300 component of event-related potentials in schizophrenic patients
1987
Effective cabergoline treatment in idiopathic restless legs syndrome
2004
Parasitic Myositis by Echinococcus alveolaris
1978
Improved therapy of myotonia with the lidocaine derivative tocainide
1980
Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia
1984